Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology Equipment

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2029908

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2029908

Nucleic Acid Isolation and Purification Market by Product, Method, Type, Application, End User, Region - Global Forecast to 2030

PUBLISHED:
PAGES: 545 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The nucleic acid isolation and purification market is expected to grow from USD 7.10 billion in 2025 to USD 10.99 billion in 2030, at a CAGR of 9.1% during the forecast period.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsProduct, Method, Type, Application, End User, and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

PCR and other NAAT workflows are routine in many infectious disease programs. Labs are expanding test menus and handling higher sample volumes. NGS is also moving deeper into clinical use cases, increasing the need for clean DNA/RNA as a first step. Declining extraction quality affects downstream sensitivity. This encourages end users to continue investing in reliable NAIP workflows and reagents.

Nucleic Acid Isolation and Purification Market - IMG1

"The magnetic-bead based isolation and purification segment accounted for the largest share, by method, in the nucleic acid isolation and purification market in 2024."

The nucleic acid isolation and purification market is segmented into magnetic bead-based isolation and purification, column-based isolation and purification, reagent-based isolation and purification, and other methods. In 2024, the magnetic bead-based isolation and purification method dominated the market. This dominance is driven by the compatibility of bead workflows with automation and high-throughput processing, which are priorities for hospitals, reference labs, and large research centers. Bead-based methods also deliver consistent yields and reproducibility across batches, helping labs reduce reruns and maintain turnaround times.

"The diagnostics segment was the largest application segment in the nucleic acid isolation and purification market in 2024."

The nucleic acid isolation and purification market is segmented by application into diagnostics, drug discovery & development, personalized medicine, agriculture & animal research, and other applications. The diagnostics segment led the market in 2024. The primary reason is that DNA/RNA extraction is a necessary first step for most PCR/NAAT assays. In addition, a growing number of sequencing-based clinical tests is supporting expansion. High routine volumes from infectious disease panels, respiratory testing, and oncology molecular assays maintain steady demand. Diagnostic labs also prioritize standardized and validated workflows to reduce variability, avoid reruns, and shorten turnaround times.

"The Asia Pacific region will grow at the highest CAGR in the nucleic acid isolation and purification market from 2025 to 2030."

The Asia Pacific region is estimated to be the fastest-growing segment of the market. This growth is supported by the expansion of population genomics programs and the rising focus on precision medicine. The region is also seeing increased demand for diagnosis and monitoring of rare and genetic diseases, especially in aging populations in markets such as Japan and China. As a result, sequencing and other molecular testing are being adopted more widely in routine healthcare.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1- 40%, Tier 2- 30% and Tier 3- 30%
  • By Designation: Directors- 20%, Managers- 10% and Others - 70%,
  • By Region: North America -35%, Europe -25%, Asia Pacific -25%, Latin America -10%, and Middle East -5%.

List of Companies Profiled in the Report:

  • Thermo Fisher Scientific Inc. (US)
  • Merck KGaA (Germany)
  • QIAGEN (Germany)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Promega Corporation (US)
  • Agilent Technologies, Inc. (US)
  • Danaher(US)
  • Bio-Rad Laboratories, Inc. (US)
  • Illumina, Inc. (US)
  • Takara Bio Inc. (Japan)
  • New England Biolabs (US)
  • Abcam Plc (UK)
  • KILPEST India Limited (India)
  • Apical Scientific Sdn. Bhd. (Malaysia)
  • Endress+Hauser Group Services AG (Switzerland)
  • GENAXXON bioscience GmbH (Germany)
  • LGC Biosearch Technologies (US)
  • Zymo Research Corporation (US)
  • Norgen Biotek Corp. (Canada)
  • Omega Bio-Tek, Inc. (US)
  • FAVORGEN Biotech Corp. (China)
  • TIANGEN Biotech (Beijing) Co., Ltd. (China)
  • AutoGen Inc. (US)
  • PCR Biosystems (UK)
  • Biogenuix (India)

Research Coverage

This research report categorizes the nucleic acid isolation and purification market by product [Kits, Reagents, Instruments (Manual, Automatic)], by type (Plasmid DNA isolation and purification, Total RNA isolation and purification, Genomic DNA isolation and purification, Messenger RNA isolation and purification, Circulating nucleic acid isolation and purification, MicroRNA isolation and purification, Other types), by method (Magnetic bead-based isolation and purification, Reagent-based isolation and purification, Column-based isolation and purification, Other methods), by application (Diagnostics, Drug discovery & development, Personalized medicine, Agriculture and animal research, Other applications), by end user (Hospitals and diagnostic centers, Academic and government research institutes, Pharmaceutical and biotechnology companies, Contract Research Organizations (CROs), Other end users), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information on the major factors, such as drivers, challenges, opportunities, and restraints, that influence the growth of the nucleic acid isolation and purification market. A detailed analysis of key industry players has been conducted to provide insights into their business overview, product portfolio, key strategies such as product launches, collaborations, partnerships, expansions, agreements, and recent developments associated with the nucleic acid isolation and purification market. Competitive analysis of top players and upcoming startups in the nucleic acid isolation and purification market ecosystem is also covered in this report.

Key Benefits of Buying the Report

The report will help market leaders and new entrants by providing the closest approximations of revenue for the overall nucleic acid isolation and purification market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain insights to better position their business and develop suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights into the following points:

Analysis of key drivers (routine PCR/qPCR and NGS testing scaling across care and research, expanding public health genomic surveillance in more countries), restraints (high cost and time required for high-volume testing), opportunities (automation impacting throughput, traceability, and staffing resilience, premium NAIP products for cfDNA, oncology, and low-input workflows), and challenges (variability due to PCR inhibitors and matrix effects) influencing the growth of the market.

  • Product Development/Innovation: Detailed insights on newly launched products of the nucleic acid isolation and purification market
  • Market Development: Comprehensive information about lucrative markets - the report analyzes the market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the nucleic acid isolation and purification market
  • Competitive Assessment: Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), QIAGEN (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Promega Corporation (US), Agilent Technologies, Inc. (US), Danaher(US), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), Takara Bio Inc. (Japan), New England Biolabs (US), Abcam Plc (UK), KILPEST India Limited (India), Apical Scientific Sdn. Bhd. (Malaysia), Endress+Hauser Group Services AG (Switzerland), GENAXXON bioscience GmbH (Germany), and LGC Biosearch Technologies (US), among others
Show more
Product Code: BT 2398

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
  • 1.4 INCLUSIONS & EXCLUSIONS
    • 1.4.1 YEARS CONSIDERED
    • 1.4.2 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

  • 2.1 MARKET HIGHLIGHTS & KEY INSIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
  • 2.4 HIGH-GROWTH SEGMENTS
  • 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET OVERVIEW
  • 3.2 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT
  • 3.3 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 3.4 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE, BY END USER, 2026 VS 2031 (%)

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Rising adoption of automated nucleic acid extraction systems
      • 4.2.1.2 Increasing need for high-purity and inhibitor-free nucleic acid recovery
      • 4.2.1.3 Broadening use of magnetic bead-based purification chemistries
      • 4.2.1.4 Growth in complex and difficult sample-type processing
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 Price pressure and partial commoditization of routine extraction kits
      • 4.2.2.2 Continued use of manual and low-cost in-house methods in small & mid-sized labs
      • 4.2.2.3 Workflow substitution in selected use cases
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Premium extraction solutions for low-input and cell-free nucleic acids
      • 4.2.3.2 Expansion of automated benchtop and mid-throughput extraction platforms
      • 4.2.3.3 Workflow integration with quantitation, tracking, and digital reporting
      • 4.2.3.4 Application-specific extraction workflows in biopharma and CGT
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Pre-analytical variability that affects extraction output
      • 4.2.4.2 Removal of inhibitors and contaminants from difficult matrices
      • 4.2.4.3 Standardization and validation for regulated or sensitive workflows
  • 4.3 UNMET NEEDS & WHITE SPACES
  • 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 THREAT OF SUBSTITUTES
    • 5.1.3 BARGAINING POWER OF BUYERS
    • 5.1.4 BARGAINING POWER OF SUPPLIERS
    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMIC OUTLOOK
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS & FORECAST
    • 5.2.3 TRENDS IN GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
    • 5.2.4 TRENDS IN HEALTHCARE EXPENDITURE
  • 5.3 VALUE CHAIN ANALYSIS
  • 5.4 SUPPLY CHAIN ANALYSIS
  • 5.5 ECOSYSTEM ANALYSIS
    • 5.5.1 EMERGING BUSINESS MODELS & ECOSYSTEM SHIFTS
  • 5.6 PRICING ANALYSIS
    • 5.6.1 INDICATIVE SELLING PRICE OF KEY PLAYERS, BY PRODUCT, 2025
    • 5.6.2 INDICATIVE SELLING PRICE OF NAIP PRODUCTS, BY REGION, 2025
  • 5.7 KEY CONFERENCES & EVENTS
  • 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.9 INVESTMENT/FUNDING ACTIVITY
  • 5.10 CASE STUDY ANALYSIS
  • 5.11 IMPACT OF 2025 US TARIFFS ON NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
    • 5.11.1 INTRODUCTION
    • 5.11.2 KEY TARIFF RATES
    • 5.11.3 PRICE IMPACT ANALYSIS
    • 5.11.4 IMPACT ON COUNTRY/REGION
      • 5.11.4.1 US
      • 5.11.4.2 Europe
      • 5.11.4.3 Asia Pacific
    • 5.11.5 IMPACT ON END-USE INDUSTRIES
      • 5.11.5.1 Hospitals & diagnostic centers
      • 5.11.5.2 Academic & government research institutes
      • 5.11.5.3 Pharmaceutical & biotechnology companies
      • 5.11.5.4 Contract research organizations (CROs)
      • 5.11.5.5 Other end users

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

  • 6.1 TECHNOLOGY ANALYSIS
    • 6.1.1 KEY TECHNOLOGIES
      • 6.1.1.1 Silica membrane/spin column purification
      • 6.1.1.2 Magnetic bead-based purification
      • 6.1.1.3 Reagent-based extraction/organic extraction
    • 6.1.2 COMPLEMENTARY TECHNOLOGIES
      • 6.1.2.1 Sample lysis & homogenization technologies
      • 6.1.2.2 Centrifugation & vacuum manifold systems
    • 6.1.3 ADJACENT TECHNOLOGIES
      • 6.1.3.1 PCR & qPCR technologies
  • 6.2 TECHNOLOGY/PRODUCT ROADMAP
  • 6.3 PATENT ANALYSIS
    • 6.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCT/TECHNOLOGY PATENTS, 2015-2025
  • 6.4 FUTURE APPLICATIONS
  • 6.5 IMPACT OF AI/GEN AI ON NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
    • 6.5.1 TOP USE CASES & MARKET POTENTIAL
    • 6.5.2 CASE STUDIES OF AI IMPLEMENTATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
    • 6.5.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
    • 6.5.4 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
  • 6.6 SUCCESS STORIES & REAL-WORLD APPLICATIONS

7 SUSTAINABILITY & REGULATORY LANDSCAPE

  • 7.1 REGULATORY LANDSCAPE
    • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.2 REGULATORY FRAMEWORK/KEY REGULATIONS
      • 7.1.2.1 North America
        • 7.1.2.1.1 US
        • 7.1.2.1.2 Canada
      • 7.1.2.2 Europe
        • 7.1.2.2.1 Germany
        • 7.1.2.2.2 France
        • 7.1.2.2.3 UK
      • 7.1.2.3 Asia Pacific
        • 7.1.2.3.1 Japan
        • 7.1.2.3.2 China
        • 7.1.2.3.3 India
        • 7.1.2.3.4 South Korea
      • 7.1.2.4 Latin America
        • 7.1.2.4.1 Brazil
      • 7.1.2.5 Middle East
        • 7.1.2.5.1 Saudi Arabia
    • 7.1.3 INDUSTRY STANDARDS
  • 7.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
  • 7.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

  • 8.1 DECISION-MAKING PROCESS
  • 8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
    • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.2.2 KEY BUYING CRITERIA, BY END USER
  • 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
  • 8.5 MARKET PROFITABILITY

9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT

  • 9.1 INTRODUCTION
  • 9.2 KITS
    • 9.2.1 KITS TO ACCOUNT FOR LARGEST SHARE OF MARKET DURING FORECAST PERIOD
  • 9.3 REAGENTS
    • 9.3.1 AVAILABILITY OF READY-TO-USE REAGENTS TO DRIVE GROWTH
  • 9.4 INSTRUMENTS
    • 9.4.1 AUTOMATIC INSTRUMENTS
      • 9.4.1.1 Benefits of automatic instruments to drive growth
    • 9.4.2 MANUAL INSTRUMENTS
      • 9.4.2.1 Growing demand for nucleic acid isolation and purification in research and clinical applications to drive growth

10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD

  • 10.1 INTRODUCTION
  • 10.2 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION
    • 10.2.1 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • 10.3 REAGENT-BASED ISOLATION AND PURIFICATION
    • 10.3.1 REAGENT-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER STEADY GROWTH DURING FORECAST PERIOD
  • 10.4 COLUMN-BASED ISOLATION AND PURIFICATION
    • 10.4.1 GROWING POPULARITY OF COLUMN-BASED ISOLATION AND PURIFICATION IN CURRENT KITS TO BOOST MARKET
  • 10.5 OTHER ISOLATION AND PURIFICATION METHODS

11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE

  • 11.1 INTRODUCTION
  • 11.2 PLASMID DNA ISOLATION AND PURIFICATION
    • 11.2.1 PLASMID DNA ISOLATION AND PURIFICATION TO ACCOUNT FOR LARGEST SHARE OF MARKET
  • 11.3 TOTAL RNA ISOLATION AND PURIFICATION
    • 11.3.1 WIDE USE OF TOTAL RNA ISOLATION AND PURIFICATION FOR RESEARCH AND DIAGNOSTIC APPLICATIONS TO BOOST MARKET
  • 11.4 GENOMIC DNA ISOLATION AND PURIFICATION
    • 11.4.1 IMPORTANCE OF GENOMIC DNA ISOLATION IN GENETIC-BASED TESTS TO SUPPORT GROWTH
  • 11.5 MESSENGER RNA ISOLATION AND PURIFICATION
    • 11.5.1 ROLE PLAYED BY MESSENGER RNA ISOLATION AND PURIFICATION IN GENE EXPRESSION AND TRANSCRIPTOMICS TO DRIVE GROWTH
  • 11.6 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION
    • 11.6.1 ABILITY OF CIRCULATING NAIP TO ENABLE COLLECTION OF GENETIC INFORMATION FROM BODY FLUIDS TO BOOST ADOPTION
  • 11.7 MICRORNA ISOLATION AND PURIFICATION
    • 11.7.1 GROWING APPLICATIONS OF MICRORNA ISOLATION AND PURIFICATION IN DRUG DEVELOPMENT RESEARCH TO FUEL GROWTH
  • 11.8 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES

12 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE

  • 12.1 INTRODUCTION
  • 12.2 CELLULAR SAMPLES
    • 12.2.1 WBCS
      • 12.2.1.1 Strong demand from routine blood-based genomics and diagnostic testing workflows to boost market
    • 12.2.2 CULTURED CELLS
      • 12.2.2.1 Core segment supporting drug discovery, cell biology, and biopharma R&D applications
    • 12.2.3 BACTERIAL
      • 12.2.3.1 Rising adoption in infectious disease, microbiome, and environmental testing workflows to fuel market growth
    • 12.2.4 OTHER CELLULAR SAMPLES
  • 12.3 PRESERVED TISSUE SAMPLES
    • 12.3.1 FRESH/FROZEN TISSUES
      • 12.3.1.1 Preferred for high-quality nucleic acid recovery in research and translational studies
    • 12.3.2 FFPE (FORMALIN-FIXED PARAFFIN-EMBEDDED)
      • 12.3.2.1 Fastest-growing segment fueled by increasing use of archived clinical samples in oncology
    • 12.3.3 OTHER PRESERVED TISSUE SAMPLES
  • 12.4 CELL-FREE SAMPLES
    • 12.4.1 CFDNA/CTDNA
      • 12.4.1.1 Key growth driver enabling liquid biopsy and real-time disease monitoring
    • 12.4.2 OTHER CELL-FREE SAMPLES
  • 12.5 OTHER SAMPLES

13 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION

  • 13.1 INTRODUCTION
  • 13.2 DIAGNOSTICS
    • 13.2.1 DIAGNOSTIC APPLICATIONS TO DOMINATE MARKET DURING FORECAST PERIOD
  • 13.3 DRUG DISCOVERY & DEVELOPMENT
    • 13.3.1 POTENTIAL OF NAIP TO HELP IN DEVELOPMENT OF DRUGS FOR RARE DISEASES TO BOOST MARKET
  • 13.4 PERSONALIZED MEDICINE
    • 13.4.1 RISING INCIDENCE OF CANCER AND INCREASING RESEARCH AND FUNDING TO DRIVE GROWTH
  • 13.5 AGRICULTURE & ANIMAL RESEARCH
    • 13.5.1 FAVORABLE FUNDING SCENARIO TO SUPPORT MARKET GROWTH
  • 13.6 OTHER APPLICATIONS

14 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER

  • 14.1 INTRODUCTION
  • 14.2 HOSPITALS & DIAGNOSTIC CENTERS
    • 14.2.1 RISING FOCUS ON PERSONALIZED MEDICINE IN HOSPITALS TO DRIVE MARKET GROWTH
  • 14.3 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
    • 14.3.1 INCREASE IN RESEARCH INTENSITY TO DRIVE USAGE OF NUCLEIC ACID ISOLATION AND PURIFICATION SYSTEMS
  • 14.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 14.4.1 INCREASING NUMBER OF RESEARCH PROJECTS IN GENOMICS AND RELATED AREAS TO DRIVE SEGMENT GROWTH
  • 14.5 CONTRACT RESEARCH ORGANIZATIONS
    • 14.5.1 CONTRACT RESEARCH ORGANIZATIONS TO REGISTER STEADY GROWTH DURING FORECAST PERIOD
  • 14.6 OTHER END USERS

15 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION

  • 15.1 INTRODUCTION
  • 15.2 NORTH AMERICA
    • 15.2.1 US
      • 15.2.1.1 Government and private funding to support market growth
    • 15.2.2 CANADA
      • 15.2.2.1 Growing investments in genomics to boost market demand
  • 15.3 EUROPE
    • 15.3.1 GERMANY
      • 15.3.1.1 Germany to dominate market in Europe
    • 15.3.2 UK
      • 15.3.2.1 Government support for research through investments, funds, and grants to support market growth
    • 15.3.3 FRANCE
      • 15.3.3.1 Increasing number of established biotech facilities to drive market growth
    • 15.3.4 ITALY
      • 15.3.4.1 Government support to drive market growth in Italy
    • 15.3.5 SPAIN
      • 15.3.5.1 High adoption of advanced diagnostic technologies to drive market growth in Spain
    • 15.3.6 REST OF EUROPE
  • 15.4 ASIA PACIFIC
    • 15.4.1 CHINA
      • 15.4.1.1 Strong domestic genomics scale and tightening IVD framework to drive NAIP adoption
    • 15.4.2 JAPAN
      • 15.4.2.1 Whole-genome medicine and structured clinical implementation to support premium NAIP demand
    • 15.4.3 INDIA
      • 15.4.3.1 National genomics initiatives and rising domestic manufacturing to expand NAIP opportunities
    • 15.4.4 AUSTRALIA
      • 15.4.4.1 Precision health funding and rare-disease genomics to support advanced NAIP workflows
    • 15.4.5 SOUTH KOREA
      • 15.4.5.1 Support from governments to drive market in region
    • 15.4.6 REST OF ASIA PACIFIC (ROAPAC)
  • 15.5 LATIN AMERICA
    • 15.5.1 BRAZIL
      • 15.5.1.1 Brazil to dominate LATAM market
    • 15.5.2 MEXICO
      • 15.5.2.1 Favorable trade agreements to support imports and improve access to NAIP instruments in Mexico
    • 15.5.3 REST OF LATIN AMERICA
  • 15.6 MIDDLE EAST
    • 15.6.1 GCC COUNTRIES
      • 15.6.1.1 Saudi Arabia
        • 15.6.1.1.1 National genomics strategy and precision medicine expansion to accelerate NAIP demand
      • 15.6.1.2 UAE
        • 15.6.1.2.1 Molecular lab standardization and genomics-led healthcare investment to strengthen NAIP adoption
      • 15.6.1.3 Rest of GCC Countries
    • 15.6.2 REST OF MIDDLE EAST
  • 15.7 AFRICA
    • 15.7.1 GOVERNMENT SUPPORT FOR RESEARCH STUDIES TO FUEL GROWTH

16 COMPETITIVE LANDSCAPE

  • 16.1 INTRODUCTION
  • 16.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
  • 16.3 REVENUE ANALYSIS, 2021-2025
  • 16.4 MARKET SHARE ANALYSIS, 2025
  • 16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 16.5.1 STARS
    • 16.5.2 EMERGING LEADERS
    • 16.5.3 PERVASIVE PLAYERS
    • 16.5.4 PARTICIPANTS
    • 16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 16.5.5.1 Company footprint
      • 16.5.5.2 Region footprint
      • 16.5.5.3 Product footprint
      • 16.5.5.4 Method footprint
      • 16.5.5.5 Application footprint
  • 16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
    • 16.6.1 PROGRESSIVE COMPANIES
    • 16.6.2 RESPONSIVE COMPANIES
    • 16.6.3 DYNAMIC COMPANIES
    • 16.6.4 STARTING BLOCKS
    • 16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
      • 16.6.5.1 List of key startups/SMEs
      • 16.6.5.2 Competitive benchmarking of key startups/SMEs
  • 16.7 COMPANY VALUATION & FINANCIAL METRICS
    • 16.7.1 FINANCIAL METRICS
    • 16.7.2 COMPANY VALUATION
  • 16.8 BRAND/PRODUCT COMPARISON
    • 16.8.1 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT
  • 16.9 COMPETITIVE SCENARIO
    • 16.9.1 PRODUCT LAUNCHES
    • 16.9.2 DEALS

17 COMPANY PROFILES

  • 17.1 KEY PLAYERS
    • 17.1.1 THERMO FISHER SCIENTIFIC INC.
      • 17.1.1.1 Business overview
      • 17.1.1.2 Products offered
      • 17.1.1.3 Recent developments
        • 17.1.1.3.1 Product launches
        • 17.1.1.3.2 Expansions
        • 17.1.1.3.3 Other developments
      • 17.1.1.4 MnM view
        • 17.1.1.4.1 Key strengths
        • 17.1.1.4.2 Strategic choices
        • 17.1.1.4.3 Weaknesses & competitive threats
    • 17.1.2 QIAGEN N.V.
      • 17.1.2.1 Business overview
      • 17.1.2.2 Products offered
      • 17.1.2.3 Recent developments
        • 17.1.2.3.1 Product launches
        • 17.1.2.3.2 Deals
      • 17.1.2.4 MnM view
        • 17.1.2.4.1 Key strengths
        • 17.1.2.4.2 Strategic choices
        • 17.1.2.4.3 Weaknesses & competitive threats
    • 17.1.3 MERCK KGAA
      • 17.1.3.1 Business overview
      • 17.1.3.2 Products offered
      • 17.1.3.3 Recent developments
        • 17.1.3.3.1 Product launches
      • 17.1.3.4 MnM view
        • 17.1.3.4.1 Key strengths
        • 17.1.3.4.2 Strategic choices
        • 17.1.3.4.3 Weaknesses & competitive threats
    • 17.1.4 F. HOFFMANN-LA ROCHE LTD.
      • 17.1.4.1 Business overview
      • 17.1.4.2 Products offered
      • 17.1.4.3 Recent developments
        • 17.1.4.3.1 Other developments
      • 17.1.4.4 MnM view
        • 17.1.4.4.1 Key strengths
        • 17.1.4.4.2 Strategic choices
        • 17.1.4.4.3 Weaknesses & competitive threats
    • 17.1.5 DANAHER CORPORATION
      • 17.1.5.1 Business overview
      • 17.1.5.2 Products offered
      • 17.1.5.3 Recent developments
        • 17.1.5.3.1 Deals
      • 17.1.5.4 MnM view
        • 17.1.5.4.1 Key strengths
        • 17.1.5.4.2 Strategic choices
        • 17.1.5.4.3 Weaknesses & competitive threats
    • 17.1.6 PROMEGA CORPORATION
      • 17.1.6.1 Business overview
      • 17.1.6.2 Products offered
      • 17.1.6.3 Recent developments
        • 17.1.6.3.1 Deals
    • 17.1.7 AGILENT TECHNOLOGIES, INC.
      • 17.1.7.1 Business overview
      • 17.1.7.2 Products offered
      • 17.1.7.3 Recent developments
        • 17.1.7.3.1 Other Developments
    • 17.1.8 BIO-RAD LABORATORIES, INC.
      • 17.1.8.1 Business overview
      • 17.1.8.2 Products offered
    • 17.1.9 ILLUMINA, INC.
      • 17.1.9.1 Business overview
      • 17.1.9.2 Products offered
      • 17.1.9.3 Recent developments
        • 17.1.9.3.1 Product launches
    • 17.1.10 TAKARA BIO INC.
      • 17.1.10.1 Business overview
      • 17.1.10.2 Products offered
    • 17.1.11 NEW ENGLAND BIOLABS
      • 17.1.11.1 Business overview
      • 17.1.11.2 Products offered
      • 17.1.11.3 Recent developments
        • 17.1.11.3.1 Product launches
    • 17.1.12 A&A BIOTECHNOLOGY
      • 17.1.12.1 Business overview
      • 17.1.12.2 Products offered
    • 17.1.13 REVVITY INC.
      • 17.1.13.1 Business overview
      • 17.1.13.2 Products offered
    • 17.1.14 BIONEER CORPORATION
      • 17.1.14.1 Business overview
      • 17.1.14.2 Products offered
    • 17.1.15 HIMEDIA LABORATORIES PRIVATE LIMITED
      • 17.1.15.1 Business overview
      • 17.1.15.2 Products offered
  • 17.2 OTHER PLAYERS
    • 17.2.1 KILPEST INDIA LIMITED
    • 17.2.2 APICAL SCIENTIFIC SDN. BHD.
    • 17.2.3 ENDRESS+HAUSER GROUP SERVICES AG
    • 17.2.4 GENAXXON BIOSCIENCE GMBH
    • 17.2.5 LGC BIOSEARCH TECHNOLOGIES
    • 17.2.6 ZYMO RESEARCH CORPORATION
    • 17.2.7 NORGEN BIOTEK CORP.
    • 17.2.8 OMEGA BIO-TEK, INC.
    • 17.2.9 FAVORGEN BIOTECH CORPORATION
    • 17.2.10 TIANGEN BIOTECH(BEIJING)CO., LTD.
    • 17.2.11 AUTOGEN INC.
    • 17.2.12 PCR BIOSYSTEMS
    • 17.2.13 BIOGENUIX
    • 17.2.14 MP BIOMEDICALS
    • 17.2.15 NANJING VAZYME BIOTECH CO., LTD.

18 RESEARCH METHODOLOGY

  • 18.1 RESEARCH DATA
    • 18.1.1 SECONDARY DATA
      • 18.1.1.1 Key data from secondary sources
    • 18.1.2 PRIMARY DATA
      • 18.1.2.1 Key data from primary sources
      • 18.1.2.2 Key primary participants
      • 18.1.2.3 Breakdown of primary interviews
      • 18.1.2.4 Key industry insights
  • 18.2 MARKET SIZE ESTIMATION
    • 18.2.1 SEGMENTAL MARKET SIZE ESTIMATION
  • 18.3 MARKET GROWTH RATE PROJECTIONS
  • 18.4 FACTOR ANALYSIS
  • 18.5 DATA TRIANGULATION
  • 18.6 RESEARCH ASSUMPTIONS
  • 18.7 RESEARCH LIMITATIONS & RISK ASSESSMENT
  • 18.8 SRISK ASSESSMENT

19 APPENDIX

  • 19.1 DISCUSSION GUIDE
  • 19.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 19.3 CUSTOMIZATION OPTIONS
  • 19.4 RELATED REPORTS
  • 19.5 AUTHOR DETAILS
Show more
Product Code: BT 2398

List of Tables

  • TABLE 1 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: IMPACT ANALYSIS
  • TABLE 2 NEXT-GENERATION SEQUENCING MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 3 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 4 HEALTH EXPENDITURE AND FINANCING, 2015-2024 (IN PERCENTAGE OF GDP)
  • TABLE 5 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: ROLE IN ECOSYSTEM
  • TABLE 6 INDICATIVE SELLING PRICE OF KEY PLAYERS, BY PRODUCT, 2025
  • TABLE 7 INDICATIVE SELLING PRICE OF NAIP PRODUCTS, BY REGION, 2025
  • TABLE 8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: KEY CONFERENCES & EVENTS, 2026-2027
  • TABLE 9 CASE STUDY 1: DNA EXTRACTION FROM ARCHEOLOGICAL AND RECENT SKELETAL REMAINS
  • TABLE 10 CASE STUDY 2: CLINICAL LAB AUTOMATION FOR ROUTINE MOLECULAR SAMPLE PREPARATION
  • TABLE 11 CASE STUDY 3: AUTOMATED EXTRACTION OF FFPE SAMPLES FOR ONCOLOGY/NGS WORKFLOWS
  • TABLE 12 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 13 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: KEY COMPANIES' TECHNOLOGY/PRODUCT ROADMAP
  • TABLE 14 DETAILED ANALYSIS OF KEY PATENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
  • TABLE 15 CASE STUDIES OF AI IMPLEMENTATION IN NUCLEIC ACID ISOLATION AND PURIFICATION
  • TABLE 16 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
  • TABLE 17 KEY SUCCESS STORIES WITH RESPECT TO REAL-WORLD APPLICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
  • TABLE 18 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 20 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 21 EUROPE: CLASSIFICATION OF DEVICES
  • TABLE 22 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 23 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 24 SOUTH KOREA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT (%)
  • TABLE 26 KEY BUYING CRITERIA, BY END USER
  • TABLE 27 UNMET NEED ACROSS DIFFERENT END USERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
  • TABLE 28 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 29 NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 30 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 31 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 32 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 33 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 34 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 35 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 36 NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 37 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 38 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 39 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 40 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 41 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 42 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 43 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 44 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 45 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 46 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 47 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 48 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 49 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 50 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 51 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 52 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 53 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 54 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 55 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 56 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 57 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 58 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 59 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 60 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 61 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 62 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 63 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 64 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 65 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 66 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 67 NORTH AMERICA: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 68 EUROPE: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 69 ASIA PACIFIC: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 70 LATIN AMERICA: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 71 MIDDLE EAST: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 72 GCC COUNTRIES: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 73 REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 74 NORTH AMERICA: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 75 EUROPE: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 76 ASIA PACIFIC: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 77 LATIN AMERICA: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 78 MIDDLE EAST: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 79 GCC COUNTRIES: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 80 COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 81 NORTH AMERICA: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 82 EUROPE: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 83 ASIA PACIFIC: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 84 LATIN AMERICA: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 85 MIDDLE EAST: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 86 GCC COUNTRIES: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 87 OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 88 NORTH AMERICA: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 89 EUROPE: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 90 ASIA PACIFIC: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 91 LATIN AMERICA: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 92 MIDDLE EAST: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 93 GCC COUNTRIES: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 94 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 95 PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 96 NORTH AMERICA: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 97 EUROPE: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 98 ASIA PACIFIC: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 99 LATIN AMERICA: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 100 MIDDLE EAST: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 101 GCC COUNTRIES: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 102 TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 103 NORTH AMERICA: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 104 EUROPE: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 105 ASIA PACIFIC: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 106 LATIN AMERICA: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 107 MIDDLE EAST: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 108 GCC COUNTRIES: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 109 GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 110 NORTH AMERICA: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 111 EUROPE: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 112 ASIA PACIFIC: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 113 LATIN AMERICA: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 114 MIDDLE EAST: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 115 GCC COUNTRIES: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 116 MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 117 NORTH AMERICA: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 118 EUROPE: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 119 ASIA PACIFIC: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 120 LATIN AMERICA: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 121 MIDDLE EAST: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 122 GCC COUNTRIES: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 123 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 124 NORTH AMERICA: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 125 EUROPE: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 126 ASIA PACIFIC: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 127 LATIN AMERICA: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 128 MIDDLE EAST: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 129 GCC COUNTRIES: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 130 MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 131 NORTH AMERICA: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 132 EUROPE: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 133 ASIA PACIFIC: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 134 LATIN AMERICA: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 135 MIDDLE EAST: MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 136 GCC COUNTRIES: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 137 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 138 NORTH AMERICA: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 139 EUROPE: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 140 ASIA PACIFIC: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 141 LATIN AMERICA: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 142 MIDDLE EAST: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 143 GCC COUNTRIES: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 144 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 145 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 146 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 147 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 148 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 150 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 151 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 152 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 153 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR WBCS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 154 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR WBCS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 155 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR WBCS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 156 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR WBCS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 157 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR WBCS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 158 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR WBCS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 159 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR WBCS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 160 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CULTURED CELLS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 161 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CULTURED CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 162 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CULTURED CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 163 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CULTURED CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 164 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CULTURED CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 165 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CULTURED CELLS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 166 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CULTURED CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 167 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR BACTERIAL CELLS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 168 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 169 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 170 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 171 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 172 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR BACTERIAL CELLS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 173 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 174 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELLULAR SAMPLES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 175 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELLULAR SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 176 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELLULAR SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 177 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELLULAR SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 178 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELLULAR SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 179 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELLULAR SAMPLES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 180 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELLULAR SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 181 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 182 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 183 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 184 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 185 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 186 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 187 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 188 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 189 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FRESH/FROZEN TISSUES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 190 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FRESH/FROZEN TISSUES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 191 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FRESH/FROZEN TISSUES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 192 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FRESH/FROZEN TISSUES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 193 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FRESH/FROZEN TISSUES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 194 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FRESH/FROZEN TISSUES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 195 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FRESH/FROZEN TISSUES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 196 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FFPE, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 197 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FFPE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 198 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FFPE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 199 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FFPE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 200 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FFPE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 201 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FFPE, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 202 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FFPE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 203 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER PRESERVED TISSUE SAMPLES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 204 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER PRESERVED TISSUE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 205 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER PRESERVED TISSUE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 206 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER PRESERVED TISSUE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 207 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER PRESERVED TISSUE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 208 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER PRESERVED TISSUE SAMPLES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 209 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER PRESERVED TISSUE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 210 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 211 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 212 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 213 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 214 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 215 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 216 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 217 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 218 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CFDNA/CTDNA, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 219 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CFDNA/CTDNA, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 220 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CFDNA/CTDNA, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 221 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CFDNA/CTDNA, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 222 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CFDNA/CTDNA, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 223 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CFDNA/CTDNA, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 224 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CFDNA/CTDNA, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 225 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELL-FREE SAMPLES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 226 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELL-FREE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 227 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELL-FREE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 228 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELL-FREE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 229 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELL-FREE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 230 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELL-FREE SAMPLES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 231 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELL-FREE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 232 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER SAMPLES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 233 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 234 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 235 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 236 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 237 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER SAMPLES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 238 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 239 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 240 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 241 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 242 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 243 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 244 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 245 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 246 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 247 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 248 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 249 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 250 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 251 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 252 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 253 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 254 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 255 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 256 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 257 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 258 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 259 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 260 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 261 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 262 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 263 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 264 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 265 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 266 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 267 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 268 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 269 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 270 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 271 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 272 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 273 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 274 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 275 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 276 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 277 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 278 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 279 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 280 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 281 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 282 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 283 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 284 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 285 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 286 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 287 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 288 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 289 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 290 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 291 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 292 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 293 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 294 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 295 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 296 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 297 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 298 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 299 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 300 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 301 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 302 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 303 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 304 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 305 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 306 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 307 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 308 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 309 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 310 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 311 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 312 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 313 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 314 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 315 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 316 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 317 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 318 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 319 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 320 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 321 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 322 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 323 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 324 US: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 325 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 326 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 327 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 328 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 329 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 330 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 331 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 332 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 333 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 334 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 335 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 336 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 337 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 338 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 339 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 340 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 341 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 342 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 343 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 344 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 345 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 346 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 347 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 348 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 349 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 350 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 351 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 352 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 353 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 354 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 355 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 356 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 357 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 358 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 359 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 360 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 361 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 362 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 363 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 364 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 365 UK: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 366 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 367 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 368 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 369 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 370 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 371 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 372 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 373 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 374 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 375 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 376 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 377 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 378 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 379 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 380 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 381 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 382 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 383 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 384 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 385 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 386 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 387 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 388 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 389 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 390 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 391 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 392 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 393 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 394 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 395 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 396 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 397 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 398 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 399 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 400 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 401 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 402 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 403 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 404 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 405 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 406 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 407 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 408 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 409 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 410 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 411 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 412 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 413 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 414 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 415 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 416 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 417 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 418 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 419 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 420 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 421 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 422 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 423 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 424 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 425 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 426 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 427 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 428 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 429 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 430 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 431 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 432 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 433 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 434 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 435 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 436 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 437 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 438 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 439 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 440 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 441 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 442 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 443 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 444 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 445 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 446 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 447 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 448 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 449 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 450 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 451 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 452 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 453 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 454 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 455 AUSTRALIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 456 AUSTRALIA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 457 AUSTRALIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 458 AUSTRALIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 459 AUSTRALIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 460 AUSTRALIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 461 AUSTRALIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 462 AUSTRALIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 463 AUSTRALIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 464 AUSTRALIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 465 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 466 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 467 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 468 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 469 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 470 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 471 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 472 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 473 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 474 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 475 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 476 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 477 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 478 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 479 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 480 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 481 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 482 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 483 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 484 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 485 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 486 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 487 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 488 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 489 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 490 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 491 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 492 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 493 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 494 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 495 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 496 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 497 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 498 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 499 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 500 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 501 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 502 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 503 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 504 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 505 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 506 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 507 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 508 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 509 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 510 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 511 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 512 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 513 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 514 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 515 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 516 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 517 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 518 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 519 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 520 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 521 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 522 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 523 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 524 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 525 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 526 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 527 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 528 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 529 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 530 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 531 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 532 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 533 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 534 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 535 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 536 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 537 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 538 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 539 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 540 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 541 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 542 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 543 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 544 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 545 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 546 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 547 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 548 SAUDI ARABIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 549 SAUDI ARABIA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 550 SAUDI ARABIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 551 SAUDI ARABIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 552 SAUDI ARABIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 553 SAUDI ARABIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 554 SAUDI ARABIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 555 SAUDI ARABIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 556 SAUDI ARABIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 557 SAUDI ARABIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 558 UAE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 559 UAE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 560 UAE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 561 UAE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 562 UAE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 563 UAE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 564 UAE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 565 UAE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 566 UAE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 567 UAE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 568 REST OF GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 569 REST OF GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 570 REST OF GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 571 REST OF GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 572 REST OF GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 573 REST OF GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 574 REST OF GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 575 REST OF GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 576 REST OF GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 577 REST OF GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 578 REST OF MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 579 REST OF MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 580 REST OF MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 581 REST OF MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 582 REST OF MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 583 REST OF MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 584 REST OF MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 585 REST OF MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 586 REST OF MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 587 REST OF MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 588 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 589 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 590 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 591 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 592 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 593 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 594 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 595 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 596 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 597 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 598 STRATEGIES ADOPTED BY KEY PLAYERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, 2023-2026
  • TABLE 599 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DEGREE OF COMPETITION
  • TABLE 600 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: REGION FOOTPRINT
  • TABLE 601 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: PRODUCT FOOTPRINT
  • TABLE 602 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: METHOD FOOTPRINT
  • TABLE 603 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: APPLICATION FOOTPRINT
  • TABLE 604 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: KEY STARTUPS/SMES
  • TABLE 605 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 606 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
  • TABLE 607 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DEALS, JANUARY 2023- APRIL 2026
  • TABLE 608 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 609 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 610 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
  • TABLE 611 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023-APRIL 2026
  • TABLE 612 THERMO FISHER SCIENTIFIC INC.: OTHER DEVELOPMENTS, JANUARY 2023-APRIL 2026
  • TABLE 613 QIAGEN N.V.: COMPANY OVERVIEW
  • TABLE 614 QIAGEN N.V.: PRODUCTS OFFERED
  • TABLE 615 QIAGEN N.V.: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
  • TABLE 616 QIAGEN N.V.: DEALS, JANUARY 2023-APRIL 2026
  • TABLE 617 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 618 MERCK KGAA: PRODUCTS OFFERED
  • TABLE 619 MERCK KGAA: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
  • TABLE 620 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
  • TABLE 621 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
  • TABLE 622 F. HOFFMANN-LA ROCHE LTD.: OTHER DEVELOPMENTS, JANUARY 2023-APRIL 2026
  • TABLE 623 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 624 DANAHER CORPORATION: PRODUCTS OFFERED
  • TABLE 625 DANAHER CORPORATION: DEALS, JANUARY 2023-APRIL 2026
  • TABLE 626 PROMEGA CORPORATION: COMPANY OVERVIEW
  • TABLE 627 PROMEGA CORPORATION: PRODUCTS OFFERED
  • TABLE 628 PROMEGA CORPORATION: DEALS, JANUARY 2023-APRIL 2026
  • TABLE 629 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 630 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
  • TABLE 631 AGILENT TECHNOLOGIES, INC.: OTHER DEVELOPMENTS, JANUARY 2023-APRIL 2026
  • TABLE 632 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 633 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
  • TABLE 634 ILLUMINA, INC.: COMPANY OVERVIEW
  • TABLE 635 ILLUMINA, INC.: PRODUCTS OFFERED
  • TABLE 636 ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
  • TABLE 637 TAKARA BIO INC.: COMPANY OVERVIEW
  • TABLE 638 TAKARA BIO INC.: PRODUCTS OFFERED
  • TABLE 639 NEW ENGLAND BIOLABS: COMPANY OVERVIEW
  • TABLE 640 NEW ENGLAND BIOLABS: PRODUCTS OFFERED
  • TABLE 641 NEW ENGLAND BIOLABS: PRODUCT LAUNCHES, JANUARY 2023-MARCH 2026
  • TABLE 642 A&A BIOTECHNOLOGY: COMPANY OVERVIEW
  • TABLE 643 A&A BIOTECHNOLOGY: PRODUCTS OFFERED
  • TABLE 644 REVVITY INC.: COMPANY OVERVIEW
  • TABLE 645 REVVITY INC.: PRODUCTS OFFERED
  • TABLE 646 BIONEER CORPORATION: COMPANY OVERVIEW
  • TABLE 647 BIONEER CORPORATION: PRODUCTS OFFERED
  • TABLE 648 HIMEDIA LABORATORIES PRIVATE LIMITED: COMPANY OVERVIEW
  • TABLE 649 HIMEDIA LABORATORIES PRIVATE LIMITED: PRODUCTS OFFERED
  • TABLE 650 KILPEST INDIA LIMITED: COMPANY OVERVIEW
  • TABLE 651 APICAL SCIENTIFIC SDN. BHD.: COMPANY OVERVIEW
  • TABLE 652 ENDRESS+HAUSER GROUP SERVICES AG: COMPANY OVERVIEW
  • TABLE 653 GENAXXON BIOSCIENCE GMBH: COMPANY OVERVIEW
  • TABLE 654 LGC BIOSEARCH TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 655 ZYMO RESEARCH CORPORATION: COMPANY OVERVIEW
  • TABLE 656 NORGEN BIOTEK CORP.: COMPANY OVERVIEW
  • TABLE 657 OMEGA BIO-TEK, INC.: COMPANY OVERVIEW
  • TABLE 658 FAVORGEN BIOTECH CORPORATION: COMPANY OVERVIEW
  • TABLE 659 TIANGEN BIOTECH(BEIJING)CO., LTD.: COMPANY OVERVIEW
  • TABLE 660 AUTOGEN INC.: COMPANY OVERVIEW
  • TABLE 661 PCR BIOSYSTEMS: COMPANY OVERVIEW
  • TABLE 662 BIOGENUIX: COMPANY OVERVIEW
  • TABLE 663 MP BIOMEDICALS: COMPANY OVERVIEW
  • TABLE 664 NANJING VAZYME BIOTECH CO., LTD.: COMPANY OVERVIEW
  • TABLE 665 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • TABLE 666 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: RISK ANALYSIS

List of Figures

  • FIGURE 1 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: YEARS CONSIDERED
  • FIGURE 3 MARKET SCENARIO
  • FIGURE 4 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, 2024-2031
  • FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, 2023-2026
  • FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
  • FIGURE 7 HIGH-GROWTH SEGMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, 2026-2031
  • FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
  • FIGURE 9 ADVANCEMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION PLATFORMS TO DRIVE MARKET GROWTH
  • FIGURE 10 KITS ACCOUNTED FOR LARGEST SHARE OF NUCLEIC ACID ISOLATION AND PURIFICATION MARKET IN NORTH AMERICA IN 2025
  • FIGURE 11 ASIA PACIFIC IS LIKELY TO BE FASTEST-GROWING MARKET IN GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET DURING FORECAST PERIOD
  • FIGURE 12 HOSPITALS & DIAGNOSTIC CENTERS TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 13 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 14 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 15 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 16 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 17 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 18 INDICATIVE SELLING PRICE OF NAIP PRODUCTS, BY TYPE, 2025
  • FIGURE 19 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 20 VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
  • FIGURE 21 TOP APPLICANTS/OWNERS (COMPANIES) FOR NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS/TECHNOLOGY PATENTS, 2015-2025
  • FIGURE 22 IMPACT OF AI/GEN AI ON NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
  • FIGURE 23 CANADA: REGULATORY PROCESS FOR MEDICAL DEVICES
  • FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT
  • FIGURE 25 KEY BUYING CRITERIA, BY END USER
  • FIGURE 26 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT
  • FIGURE 27 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT
  • FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, 2021-2025 (USD MILLION)
  • FIGURE 29 MARKET SHARE ANALYSIS OF KEY PLAYERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET (2025)
  • FIGURE 30 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 31 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY FOOTPRINT
  • FIGURE 32 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 33 EV/EBITDA OF KEY VENDORS
  • FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 35 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT
  • FIGURE 36 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 37 QIAGEN N.V.: COMPANY SNAPSHOT (2025)
  • FIGURE 38 MERCK KGAA: COMPANY SNAPSHOT (2025)
  • FIGURE 39 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025)
  • FIGURE 40 DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
  • FIGURE 41 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 42 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 43 ILLUMINA, INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 44 TAKARA BIO INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 45 REVVITY INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 46 BIONEER CORPORATION: COMPANY SNAPSHOT (2025)
  • FIGURE 47 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: RESEARCH DESIGN
  • FIGURE 48 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BREAKDOWN OF PRIMARIES
  • FIGURE 49 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: INSIGHTS FROM PRIMARIES
  • FIGURE 50 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET ESTIMATION (SUPPLY-SIDE ANALYSIS), 2025
  • FIGURE 51 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH) (2025)
  • FIGURE 52 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE ANALYSIS (2025)
  • FIGURE 53 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 54 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: CAGR PROJECTIONS
  • FIGURE 55 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DATA TRIANGULATION
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!